.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Deloitte
UBS
AstraZeneca
Queensland Health
US Army
Accenture
Covington
Chinese Patent Office
Merck

Generated: November 20, 2017

DrugPatentWatch Database Preview

Viva Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for VIVA HLTHCARE, and what generic and branded alternatives to VIVA HLTHCARE drugs are available?

VIVA HLTHCARE has four approved drugs.



Summary for Viva Hlthcare

US Patents:0
Tradenames:4
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Viva Hlthcare
MEFENAMIC ACID
mefenamic acid
CAPSULE;ORAL090562-001Nov 19, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL091541-002Sep 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
SIMVASTATIN
simvastatin
TABLET;ORAL090383-003Sep 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
SIMVASTATIN
simvastatin
TABLET;ORAL090383-001Sep 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL091541-001Sep 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
SIMVASTATIN
simvastatin
TABLET;ORAL090383-004Sep 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
SIMVASTATIN
simvastatin
TABLET;ORAL090383-002Sep 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
LOSARTAN POTASSIUM
losartan potassium
TABLET;ORAL091541-003Sep 24, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
SIMVASTATIN
simvastatin
TABLET;ORAL090383-005Sep 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Viva Hlthcare
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION206713-001Jun 27, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Teva
Boehringer Ingelheim
Deloitte
Citi
US Army
UBS
Cantor Fitzgerald
Mallinckrodt
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot